Paperpal Prime Logo

Cancer Cell International : Impact Factor & More

eISSN: 1475-2867pISSN: 1475-2867
JournalOpen Access

Key Metrics

CiteScore
6.8
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q3Genetics
SNIP
1.07
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Cell International

Cancer Cell International Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2390 | USD 2890 | GBP 2090
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Cancer Cell International ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Cell International

Single-cell-marker-based subtyping and multi-level analyses uncover the prognostic effects, dysregulations and therapeutic indicative potential of an eight-gene signature in lung adenocarcinoma.
  • 30 Jun 2026
  • Cancer cell international
CD90 mediates gastric cancer immune evasion though regulating IGF2BP2 to stabilize the m6A-CD47/SIRPα axis.
  • 30 Jun 2026
  • Cancer cell international
Evaluation of ACMG/AMP guidelines for classifying APC variants in Korean patients with suspected familial adenomatous polyposis.
  • 30 Jun 2026
  • Cancer cell international
Correction: ZNF655 promotes tumor growth and chemoresistance by targeting MAFF-CCND1 axis in ovarian cancer.
  • 29 Jun 2026
  • Cancer cell international
The novel oleanolic acid derivative ZQL-4c modulates trastuzumab resistance in HER2+ breast cancer by inhibiting SCD-mediated lipid metabolism disorders.
  • 24 Jun 2026
  • Cancer cell international
TMEM33 regulates the proliferation and migration of lung adenocarcinoma by promoting the PI3K/AKT/mTOR signaling pathway.
  • 24 Jun 2026
  • Cancer cell international
Single-cell-marker-based subtyping and multi-level analyses uncover the prognostic effects, dysregulations and therapeutic indicative potential of an eight-gene signature in lung adenocarcinoma.
  • 30 Jun 2026
  • Cancer cell international
CD90 mediates gastric cancer immune evasion though regulating IGF2BP2 to stabilize the m6A-CD47/SIRPα axis.
  • 30 Jun 2026
  • Cancer cell international
Evaluation of ACMG/AMP guidelines for classifying APC variants in Korean patients with suspected familial adenomatous polyposis.
  • 30 Jun 2026
  • Cancer cell international
Correction: ZNF655 promotes tumor growth and chemoresistance by targeting MAFF-CCND1 axis in ovarian cancer.
  • 29 Jun 2026
  • Cancer cell international
The novel oleanolic acid derivative ZQL-4c modulates trastuzumab resistance in HER2+ breast cancer by inhibiting SCD-mediated lipid metabolism disorders.
  • 24 Jun 2026
  • Cancer cell international
TMEM33 regulates the proliferation and migration of lung adenocarcinoma by promoting the PI3K/AKT/mTOR signaling pathway.
  • 24 Jun 2026
  • Cancer cell international

FAQs on Cancer Cell International